Q2 EPS Estimates for Select Medical Increased by Analyst

Select Medical Holdings Corporation (NYSE:SEM) – Research analysts at Zacks Research increased their Q2 2026 earnings per share estimates for shares of Select Medical in a research report issued on Thursday, May 14th. Zacks Research analyst Team now anticipates that the health services provider will post earnings per share of $0.30 for the quarter, up from their prior estimate of $0.28. Zacks Research has a “Hold” rating on the stock. The consensus estimate for Select Medical’s current full-year earnings is $1.26 per share. Zacks Research also issued estimates for Select Medical’s Q1 2027 earnings at $0.44 EPS and Q2 2027 earnings at $0.37 EPS.

Select Medical (NYSE:SEM) last posted its quarterly earnings results on Thursday, April 30th. The health services provider reported $0.36 EPS for the quarter, missing the consensus estimate of $0.43 by ($0.07). Select Medical had a return on equity of 6.62% and a net margin of 2.42%.The company had revenue of $1.42 billion for the quarter, compared to analysts’ expectations of $1.41 billion. During the same quarter in the prior year, the firm earned $0.44 EPS. The firm’s revenue was up 5.0% on a year-over-year basis. Select Medical has set its FY 2026 guidance at 1.220-1.320 EPS.

Several other research analysts have also commented on SEM. Royal Bank Of Canada reiterated a “sector perform” rating and set a $16.50 price target (down from $19.00) on shares of Select Medical in a report on Tuesday, March 3rd. Weiss Ratings upgraded Select Medical from a “sell (d+)” rating to a “hold (c-)” rating in a report on Friday, February 20th. Wall Street Zen lowered Select Medical from a “buy” rating to a “hold” rating in a report on Monday, March 9th. Mizuho reiterated a “neutral” rating and set a $16.50 price target (down from $17.00) on shares of Select Medical in a report on Tuesday, May 12th. Finally, Benchmark lowered Select Medical from a “buy” rating to a “hold” rating in a report on Wednesday, March 4th. One equities research analyst has rated the stock with a Buy rating and six have issued a Hold rating to the company. Based on data from MarketBeat.com, the company presently has a consensus rating of “Hold” and a consensus price target of $15.50.

Select Medical Stock Down 0.0%

NYSE SEM opened at $16.50 on Tuesday. Select Medical has a 52 week low of $11.65 and a 52 week high of $16.99. The company has a quick ratio of 1.15, a current ratio of 1.15 and a debt-to-equity ratio of 0.88. The business’s fifty day simple moving average is $16.36 and its 200-day simple moving average is $15.42. The firm has a market cap of $2.05 billion, a PE ratio of 15.56, a P/E/G ratio of 0.95 and a beta of 1.02.

Select Medical Dividend Announcement

The firm also recently disclosed a quarterly dividend, which will be paid on Thursday, May 28th. Investors of record on Thursday, May 14th will be given a dividend of $0.0625 per share. This represents a $0.25 dividend on an annualized basis and a dividend yield of 1.5%. The ex-dividend date of this dividend is Thursday, May 14th. Select Medical’s dividend payout ratio (DPR) is presently 23.58%.

Select Medical announced that its Board of Directors has initiated a share buyback program on Thursday, February 19th that allows the company to buyback $1.00 billion in outstanding shares. This buyback authorization allows the health services provider to repurchase up to 49.5% of its stock through open market purchases. Stock buyback programs are usually a sign that the company’s board of directors believes its shares are undervalued.

Institutional Trading of Select Medical

Hedge funds and other institutional investors have recently modified their holdings of the business. Quarry LP acquired a new stake in shares of Select Medical during the 4th quarter worth about $26,000. Caitong International Asset Management Co. Ltd acquired a new stake in shares of Select Medical during the 4th quarter worth about $28,000. Quantbot Technologies LP acquired a new position in Select Medical in the 3rd quarter valued at about $27,000. Hantz Financial Services Inc. increased its stake in Select Medical by 214.7% during the fourth quarter. Hantz Financial Services Inc. now owns 2,549 shares of the health services provider’s stock worth $38,000 after purchasing an additional 1,739 shares during the period. Finally, Smartleaf Asset Management LLC increased its stake in Select Medical by 37.8% during the fourth quarter. Smartleaf Asset Management LLC now owns 2,870 shares of the health services provider’s stock worth $43,000 after purchasing an additional 788 shares during the period. 89.48% of the stock is owned by institutional investors and hedge funds.

Select Medical Company Profile

Select Medical is a leading provider of specialized healthcare services in the United States, operating through two primary business segments: Hospital Division and Outpatient Rehabilitation Division. The Hospital Division offers long-term acute care (LTAC) hospitals and inpatient rehabilitation facilities (IRFs) that serve patients recovering from complex illnesses, trauma or surgery. The Outpatient Rehabilitation Division delivers physical, occupational and speech therapy services through a network of clinic locations and home-based care programs.

Headquartered in Mechanicsburg, Pennsylvania, Select Medical was founded in 1996 and has grown through strategic partnerships, joint ventures and acquisitions.